| 今开：4.81 | 昨收：4.81 |
| 最高：4.84 | 最低：4.525 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：2.82163405E8 |
OYang10-28 19:28
#药闻简讯# $Aldeyra Therapeutics(ALDX)$ 宣布酒精性肝炎二期临床试验结果积极，聚焦下一代分子 RASP 产品候选管线
相对于基线，用于酒精相关肝病的信号发现分子 ADX‑629 在肝功能方面显示出统计学上的显著改善
ADX-629，一种用于概念验证临床试验的信号发现 RASP 调节剂，在一项针对四...查看全文
OYang08-28 22:22
#药闻简讯# $Aldeyra Therapeutics(ALDX)$ 获得欧洲药品管理局对 ADX-2191 用于治疗免疫特权部位原发性大 B 细胞淋巴瘤的孤儿药认定，包括原发性视网膜脉络膜淋巴瘤查看全文
Aldeyra Therapeutics(ALDX)08-16 04:15
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-109391 Size: 4 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)11-06 05:25
$Aldeyra Therapeutics(ALDX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-266989 Act: 34 Size: 8 MB 网页链接查看全文
Aldeyra Therapeutics(ALDX)08-14 06:05
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-108210 Size: 5 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)08-15 04:35
$Aldeyra Therapeutics(ALDX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000950170-25-108920 Act: 34 Size: 10 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)08-19 19:05
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, item 9.01 Accession Number: 0000950170-25-109932 Act: 34 Size: 275 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)08-13 05:55
$Aldeyra Therapeutics(ALDX)$ 144 Report of proposed sale of securities Accession Number: 0001836354-25-000003 Act: 33 Size: 4 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)10-28 19:05
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-252200 Act: 34 Size: 486 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)2022-07-12 19:21
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001157523-22-000837 Act: 34 Size: 4 MB 网页链接查看全文
Aldeyra Therapeutics(ALDX)2022-07-09 05:07
$Aldeyra Therapeutics(ALDX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-010241 Act: 34 Size: 12 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)2022-06-27 18:48
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024132 Size: 5 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)2022-06-27 18:48
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024133 Size: 5 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)2022-06-10 05:12
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-021626 Size: 8 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)2022-06-10 05:12
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-021633 Size: 10 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)2022-06-10 05:12
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-021632 Size: 10 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)2022-06-10 05:12
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-021634 Size: 10 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)2022-06-10 05:12
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-021637 Size: 8 KB 网页链接查看全文
Aldeyra Therapeutics(ALDX)2022-06-10 05:12
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-021638 Size: 10 KB 网页链接查看全文
一、开场介绍
会议时间： 未明确提及具体日期
主持人说明：
会议为HC Wainwright全球投资会议，由该公司资深生物技术分析师Matthew Caufield主持，目的是与Aldeyra Therapeutics公司CEO Todd Brady讨论公司管线进展。
管理层发言摘要：
Todd Brady（CEO）：重点介绍了公司主要候...
一、开场介绍
会议时间： H.C. Wainwright第五届年度眼科会议
主持人说明：
Matthew Caufield介绍会议目的，欢迎Aldeyra Therapeutics首席执行官Todd Brady博士参与讨论。
管理层发言摘要：
Todd Brady强调公司从眼科起步的免疫学平台定位，重点介绍RASP（活性醛类物质）调节技...
$Aldeyra Therapeutics(ALDX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-266989 Act: 34 Size: 8 MB 网页链接
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-252200 Act: 34 Size: 486 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, item 9.01 Accession Number: 0000950170-25-109932 Act: 34 Size: 275 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-109391 Size: 4 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000950170-25-108920 Act: 34 Size: 10 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-108210 Size: 5 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ 144 Report of proposed sale of securities Accession Number: 0001836354-25-000003 Act: 33 Size: 4 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-25-104971 Act: 34 Size: 8 MB 网页链接
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001213900-25-064869 Act: 34 Size: 217 KB 网页链接
$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001213900-25-058035 Act: 34 Size: 232 KB 网页链接